Lignin processing – challenges and limits
Lignin is the least abundant of the three main wood components. In the past two decades, much research has been done on lignin processing. It hasn’t resulted in major industrial
Perspectives for agriculture – the new farming
The Dutch farmers manifest themselves. They block highways and distribution centres. They pay a visit to the homes of ministers. They oppose plans to reduce appreciably manure production and ammonia
Chemistry vs. bacteria, # 71. The future of pharma in 3 acts, no.3. Towards a holistic approach
Until quite recently, professionals in healthcare tended to look upon body and mind as strictly separated therapeutic entities. And we still don’t treat them a being equal. The notion that
Chemistry vs. bacteria, # 70. The future of pharma in 3 acts, no.2. The promises of biology
We already went into promises of biotechnology and of biological preparations (a.o. in no.54, If chemistry and biology join forces). Biology makes less progress than hoped for, and its successes
Chemistry vs. bacteria, # 69. The future of pharma in 3 acts, no. 1. More of the same
What does the future of pharma look like? So far, our task was easy, a description of history. Now things become much more difficult. There is a multitude of subjects
Chemistry vs. bacteria, # 64. Fungal infections
Fungi are the producers of our most important antibiotics. But they can also be a burden, even a threat at times. Here we will not go into relatively innocent and
Chemistry vs. bacteria, # 63. Modern vaccines
In our conflict with bacteria, we make much more use of tablets and powders than of vaccines. TBC treatment is an exception, all the more so because the tuberculosis bacterium
Do we need to regulate Big Pharma?
In Dutch newspaper NRC of July 23, 2022, Joost Smiers tackles the problem of the sky-high prices of medication. Do we still need Big Pharma? he asks. And he answers:
on: 31 July 2022